Stockchase Opinions

Jim Cramer - Mad Money Organon OGN-N DON'T BUY May 22, 2023

It has no growth.

$20.850

Stock price when the opinion was issued

Pharma & Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

BUY

Spun off from Merck two years, but has been sitting in the penalty box. Pays a 5.5% dividend at 5x earnings. 

DON'T BUY

Recently on a downward trend. Fundamentally scores 3/10. Would not recommend buying. Price target falling. Has not been able to beat earnings. Better options available for investors. High debt levels not good for dividend outlook.